HAG
ARNA

HighPoint Advisor Group’s Arena Pharmaceuticals Inc ARNA Stock Holding History

HighPoint Advisor Group’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-1,415
Closed -$24K – 245
2015
Q4 		$24K Buy
+1,415
New +$28.9K 0.02% 199

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return

HighPoint Advisor Group's ARNA Position: Q1 2016 in Review

HighPoint Advisor Group sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2016, closing a stake of 1,415 shares — an estimated $24K sold.

HighPoint Advisor Group first reported a position in ARNA in Q4 2015 and held it in 1 quarter. The position peaked at $24K in Q4 2015. 111 funds tracked by Wall St. Rank hold ARNA as of Q1 2016.

  • HighPoint Advisor Group reported no remaining Arena Pharmaceuticals Inc position as of Q1 2016 after selling out during the quarter.
  • HighPoint Advisor Group sold 1,415 Arena Pharmaceuticals Inc shares in Q1 2016, an estimated $24K.
  • HighPoint Advisor Group first reported a position in Arena Pharmaceuticals Inc in Q4 2015 and held it in 1 quarter.
  • HighPoint Advisor Group's Arena Pharmaceuticals Inc position peaked at $24K in Q4 2015.
  • 111 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2016.

Based on HighPoint Advisor Group's 13F filing for Q1 2016, filed 26 Apr 2016.